Developmental Pharmacology and Toxicology: Role of Ontogeny (R21)

Archived

National Institutes of Health

Description

This Funding Opportunity Announcement (FOA) encourages grant applications for research related to developmental pharmacology and toxicology. A major goal is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence.

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedAug 5, 2013
  • ClosesSep 7, 2016
  • Award ceiling$200,000
  • CFDA93.113, 93.865

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro